{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:28:08Z","timestamp":1793647688496,"version":"4.5.1"},"reference-count":42,"publisher":"Informa UK Limited","issue":"28","license":[{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2024,9,4]]},"DOI":"10.1080\/14796694.2024.2355863","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T07:02:17Z","timestamp":1729494137000},"page":"2049-2057","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":31,"title":["IMbrave152\/SKYSCRAPER-14: a Phase III study of atezolizumab, bevacizumab\u00a0and tiragolumab in advanced hepatocellular carcinoma"],"prefix":"10.1080","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7159-098X","authenticated-orcid":false,"given":"Shreya","family":"Badhrinarayanan","sequence":"first","affiliation":[{"name":"Clinical Development Oncology,\u00a0Genentech Inc., South San Francisco, CA,\u00a0USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Cotter","sequence":"additional","affiliation":[{"name":"Clinical Development Oncology,\u00a0Genentech Inc., South San Francisco, CA,\u00a0USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqi","family":"Zhu","sequence":"additional","affiliation":[{"name":"Clinical Development Oncology,\u00a0Genentech Inc., South San Francisco, CA,\u00a0USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3660-4570","authenticated-orcid":false,"given":"Ya-Chen","family":"Lin","sequence":"additional","affiliation":[{"name":"Clinical Development Oncology,\u00a0Genentech Inc., South San Francisco, CA,\u00a0USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Medicine,\u00a0Kindai University Faculty of Medicine, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daneng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Therapeutics Research,\u00a0City of Hope Comprehensive Cancer Center, Duarte, CA\u00a0USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"key":"e_1_3_6_3_1","unstructured":"International Agency for Research on Cancer World Health Organization [Internet]. International Agency for Research on Cancer Lyon France. 2024. Available from: https:\/\/gco.iarc.fr\/today\/home"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713263"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00240-3"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30010-2"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i3.406"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.018"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.02.032"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0162"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000466"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2017.022996"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00326-6"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100070"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00469-2"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00961-3"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30207-1"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.030"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.4_suppl.379"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.08.032"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1674"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003081"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2014.10.018"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.10.002"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0903474106"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545480"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-825265"},{"issue":"4","key":"e_1_3_6_30_1","first-page":"3773","article-title":"Expression of TIGIT\/CD155 and correlations with clinical pathological features in human hepatocellular carcinoma","volume":"20","author":"Duan X","year":"2019","unstructured":"Duan X, Liu J, Cui J, et al. Expression of TIGIT\/CD155 and correlations with clinical pathological features in human hepatocellular carcinoma. Mol Med Rep. 2019;20(4):3773\u20133781.","journal-title":"Mol Med Rep."},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-019-02426-5"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.2102.2102"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.4138.4138"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.05.035"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00226-1"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.3_suppl.245"},{"key":"e_1_3_6_37_1","volume-title":"Atezolizumab (U.S. Package Insert).","author":"Tecentriq","year":"2020","unstructured":"Tecentriq. Atezolizumab (U.S. Package Insert). Genentech, Inc.; 2020."},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01800-3"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.950536"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-023-00681-8"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01868-2"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07121-9"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.4010"},{"key":"e_1_3_6_44_1","volume-title":"A study evaluating atezolizumab and bevacizumab, with or without tiragolumab, in participants with untreated locally advanced or metastatic hepatocellular carcinoma (IMbrave152) (SKYSCRAPER-14).","author":"ClinicalTrials.gov [Internet]","unstructured":"ClinicalTrials.gov [Internet]. A study evaluating atezolizumab and bevacizumab, with or without tiragolumab, in participants with untreated locally advanced or metastatic hepatocellular carcinoma (IMbrave152) (SKYSCRAPER-14). National Library of Medicine, Bethesda (MD). https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05904886"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2024.2355863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T07:02:29Z","timestamp":1729494149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2024.2355863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":42,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2024,9,4]]}},"alternative-id":["10.1080\/14796694.2024.2355863"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2024.2355863","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-04-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}